Tagged:

Africa Eyes Single-Dose HPV Shot to Boost Cervical Cancer Fight

Cervical cancer presents a substantial challenge in sub-Saharan Africa, accounting for 120,000 cases annually out of the global total of 690,000, compounded by the HIV epidemic.

To accelerate progress against cervical cancer, the WHO Africa Regional Immunization Technical Advisory Group (RITAG) advocated for the adoption of a single-dose schedule for the human papillomavirus (HPV) vaccine in Africa, aligning with WHO recommendations from 2022.

As of November 2023, 27 African nations have included the HPV vaccine in routine immunization, yet coverage remains low at 33%, falling short of the global target of 90%. Togo and Nigeria introduced the vaccine, but challenges like limited supply persist. Countries such as Cameroon and Cabo Verde have shown adaptability by transitioning to a single-dose regimen and expanding vaccination to include boys.

InFocus

WHO Africa

Zambia steps up cervical cancer screening with HPV testing.

Follow AllAfrica

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.